These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31658979)
21. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Helb DA; Tetteh KK; Felgner PL; Skinner J; Hubbard A; Arinaitwe E; Mayanja-Kizza H; Ssewanyana I; Kamya MR; Beeson JG; Tappero J; Smith DL; Crompton PD; Rosenthal PJ; Dorsey G; Drakeley CJ; Greenhouse B Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4438-47. PubMed ID: 26216993 [TBL] [Abstract][Full Text] [Related]
22. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria. Ahmed Ismail H; Tijani MK; Langer C; Reiling L; White MT; Beeson JG; Wahlgren M; Nwuba R; Persson KE Malar J; 2014 Nov; 13():425. PubMed ID: 25373511 [TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189 [TBL] [Abstract][Full Text] [Related]
24. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas. Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641 [TBL] [Abstract][Full Text] [Related]
25. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102 [TBL] [Abstract][Full Text] [Related]
26. Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission. Sakamoto H; Takeo S; Takashima E; Miura K; Kanoi BN; Kaneko T; Han ET; Tachibana M; Matsuoka K; Sattabongkot J; Udomsangpetch R; Ishino T; Tsuboi T Parasitol Int; 2018 Apr; 67(2):203-208. PubMed ID: 29217416 [TBL] [Abstract][Full Text] [Related]
27. Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure. Kessler A; Campo JJ; Harawa V; Mandala WL; Rogerson SJ; Mowrey WB; Seydel KB; Kim K Malar J; 2018 Apr; 17(1):178. PubMed ID: 29695240 [TBL] [Abstract][Full Text] [Related]
33. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria. McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955 [TBL] [Abstract][Full Text] [Related]
34. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania. Bousema T; Roeffen W; Meijerink H; Mwerinde H; Mwakalinga S; van Gemert GJ; van de Vegte-Bolmer M; Mosha F; Targett G; Riley EM; Sauerwein R; Drakeley C PLoS One; 2010 Nov; 5(11):e14114. PubMed ID: 21124765 [TBL] [Abstract][Full Text] [Related]
35. Heterogeneity in the acquisition of naturally acquired antibodies to cell-traversal protein for ookinetes and sporozoites (CelTOS) and thrombospondin-related adhesion protein (TRAP) of Plasmodium falciparum in naturally infected patients from unstable malaria areas in Iran. Pirahmadi S; Zakeri S; Mehrizi AA; Karimi L; Djadid ND Acta Trop; 2019 Feb; 190():365-374. PubMed ID: 30543766 [TBL] [Abstract][Full Text] [Related]
36. Antigenicity and immune correlate assessment of seven Plasmodium falciparum antigens in a longitudinal infant cohort from northern Ghana. Kusi KA; Aguiar J; Kumordjie S; Aggor F; Bolton J; Renner A; Kyei-Baafour E; Puplampu N; Belmonte M; Dodoo D; Gyan BA; Ofori MF; Oduro AR; Atuguba F; Koram KA; Adams N; Letizia A; Villasante E; Sedegah M Sci Rep; 2019 Jun; 9(1):8621. PubMed ID: 31197225 [TBL] [Abstract][Full Text] [Related]
37. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Riley EM; Allen SJ; Wheeler JG; Blackman MJ; Bennett S; Takacs B; Schönfeld HJ; Holder AA; Greenwood BM Parasite Immunol; 1992 May; 14(3):321-37. PubMed ID: 1625908 [TBL] [Abstract][Full Text] [Related]
38. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants. Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP Malar J; 2019 Jan; 18(1):19. PubMed ID: 30670032 [TBL] [Abstract][Full Text] [Related]
39. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244 [TBL] [Abstract][Full Text] [Related]
40. Synthetic Antigens Derived from Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]